Close Menu

NEW YORK – The Canadian government and Becton Dickinson said on Tuesday that it has agreed to buy 7.6 million rapid, point-of-care SARS-CoV-2 antigen tests from the company.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.